China’s JE vaccine gains GAVI support, enters global marketplace

China has the largest vaccine manufacturing capacity in the world, but has yet to really make its mark in the global vaccine marketplace. While Chinese firms primarily make vaccines the domestic market, an entry into global health could have a significant effect, potentially driving down vaccine prices and accelerating global immunization efforts. Up until October, however, no Chinese-made vaccine had …

The future of capital? Crowdfunding in vaccine research

In August 2013, crowdfunders raised $12,814,216 to fund the development and release of a new smartphone, the Ubuntu Edge. The millions of dollars raised on crowdfunding website Indiegogo wasn’t enough to reach the Ubuntu Edge’s ambitious fundraising target, but it is a sign that crowdfunding can raise big dollars. Crowdfunding is a new breed of online fundraising where members of …

GSK, Sanofi Pasteur partner with Gates Foundation to accelerate vaccine R&D

GlaxoSmithKline and Sanofi Pasteur have each announced a partnership with the Bill & Melinda Gates Foundation (BMGF) through the newly created Vaccine Discovery Partnership (VxDP). The VxDP is a BMGF initiative that aims to drive advances in vaccine R&D through collaboration with vaccine-pharmaceutical companies, biotechnology institutions, NGOs and academia. The partnership with GSK will focus on research into vaccine thermostability, …

Sanofi vaccine sales drop a one-off, says Viehbacher

Sanofi’s third-quarter vaccine sales fell 7.2%, Reuters has reported. But CEO Chris Viehbacher has ascribed the slump in sales to a manufacturing issue at Sanofi’s Toronto vaccine plant, which led to a shortage in the US market of the company’s paediatric vaccines. The manufacturing problem has now been resolved and shipping of the vaccines has restarted. Sanofi doesn’t expect its …

Dendreon said to be hunting for buyer–will they find one?

Dendreon Corp, the manufacturers of prostate cancer vaccine Provenge, may face an uphill battle in finding a buyer, Bloomberg reports. The company is reportedly working with JPMorgan Chase to find a buyer, but analysts have said that intensifying competition and disappointing sales of Provenge may mean potential suitors are unlikely to come forward. One of the problems Dendreon has had …

Industry trends in vaccine dealmaking – 2007 to 2013

Blogged on behalf of Current Partnering, Wildwood Ventures Industry trends suggest that vaccine research and development is an increasingly active component of healthcare business development. In recent years vaccine partnering and M&A activity has significantly increased. This article is abstracted from the recently published Vaccine Partnering Terms & Agreements report. Vaccine partnering has increased in frequency since 2007, to peak …

eBook: CMO selection for Vaccine candidates: The decision-making processes of Pharma & Biotech

In a little over 5 months time, the World Vaccine Congress will once again be heading to Washington DC. In preparation for the event, we will producing content that we feel is relevant to the industry. To begin with, we asked the question: What decision-making processes lead to CMO selection for Vaccine candidates? The development of a new vaccine is …

Partnering to Deliver Vaccines

In April 2013 over 500 delegates participated in the 13th Annual World Vaccine Congress Washington. This event brings together vaccine leaders and policy makers from around the globe. Attendees at this highly successful event were fortunate enough to hear this exciting presentation delivered by George Adams and Christophe Coutourier from EMD MIllipore, entitled: ‘Partnering to Deliver Vaccines' This presentation outlines: …